The investment research system of BOZE is composed of talented financial investors and pharmaceutical experts. The system now contains over 20 members, and the investment managers have an average investing experience of over 15 years in domestic and international large, non-private funds or in the pharmaceutical industry. The pharmaceutical expert team shows a deep understanding of domestic pharmaceutical industry policies, and can spot investment value from an industrial perspective. The asset allocation expert team is made up of accomplished people in the field who have years of practice in global asset allocation.

Keeping faith with “research creates value”, BOZE attaches great importance to the construction of the analyst team and the investment of research resources and regards them as the basis for various businesses. Graduated from the universities of 985 Project and other world-renowned universities, BOZE analysts have years of experience in global market research on consumption, finance, clean energy, technology, and pharmaceutical. Based on fundamental research, BOZE research possesses a global perspective, focuses on the “circle of competence”, and persistently outputs forward-looking views and independent opinions to the company and the market. BOZE analyst team has continuously developed its research capabilities, and comprehensively supports the company’s investment system.